Skip to Content

Welcome to Revance

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including our next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection.

We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.

Aesthetics

We are building a prestige aesthetics franchise with a combination of products and services that offer practices and patients leading, differentiated and innovative solutions that provide real value.

Learn More

Therapeutics

We are innovating new therapeutic treatments that meaningfully transform patient experiences in muscle movement and pain disorders

Learn More

Meet the Board of Directors

Our board brings together exceptional executives in science, healthcare, and business who dare to make a difference.

Aubrey Rankin

President, Innovation & Technology of Revance Therapeutics, Inc.

Our Leadership

Daring to Make a Difference.

Revance’s leadership is committed to disrupting the status quo and has deep experience commercializing products in highly competitive markets. As a group, we represent more than a century of experience launching innovative products that change people’s lives.

We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.

Dwight Moxie

Senior Vice President, General Counsel & Corporate Secretary

Aubrey Rankin

President, Innovation & Technology of Revance Therapeutics, Inc.

Justin Ford

Senior Vice President, Human Resources and Head of People

Back to top